Publisher: AACR   (Total: 3 journals)   [Sort alphabetically]

Showing 1 - 3 of 3 Journals sorted by number of followers
Cancer Research     Hybrid Journal   (Followers: 65, SJR: 4.26, CiteScore: 7)
Clinical Cancer Research     Hybrid Journal   (Followers: 49, SJR: 4.929, CiteScore: 8)
Cancer Discovery     Hybrid Journal   (Followers: 29, SJR: 6.996, CiteScore: 5)
Similar Journals
Cancer Discovery
Journal Prestige (SJR): 6.996
Citation Impact (citeScore): 5
Number of Followers: 29  
 
  Hybrid Journal Hybrid journal (It can contain Open Access articles)
ISSN (Print) 2159-8274 - ISSN (Online) 2159-8290
Published by AACR Homepage  [3 journals]
  • 689626"> In This Issue

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689607"> Think Globally, Act Locally: Globalizing Precision Oncology

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689583"> Patchwork Cancer Predisposition

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689582"> Vive la Resistance: T-cell Immunity in the Protection against
           SARS-CoV-2 Infection

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689581"> RAS at 40: Update from the RAS Initiative

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689580"> A Structure is Worth a Thousand Words: New Insights for RAS and
           RAF Regulation

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689610"> Classification of KRAS-Activating Mutations and the Implications
           for Therapeutic Intervention

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689602"> Expanding the Reach of Precision Oncology by Drugging All KRAS
           Mutants

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689606"> Genomic Landscape and Clinical Utility in Korean Advanced
           Pan-Cancer Patients from Prospective Clinical Sequencing: K-MASTER Program
           

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689609"> Cancer-Causative Mutations Occurring in Early Embryogenesis

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689612"> The Polarity and Specificity of Antiviral T Lymphocyte Responses
           Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer
           and Healthy Individuals

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689605"> Early Tumor-Immune Microenvironmental Remodeling and Response to
           First-Line Fluoropyrimidine and Platinum Chemotherapy in Advanced Gastric
           Cancer

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689611"> Targeting S100A9-ALDH1A1-Retinoic Acid Signaling to Suppress
           Brain Relapse in EGFR-Mutant Lung Cancer

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689625"> Ontogeny and Vulnerabilities of Drug-Tolerant Persisters in HER2+
           Breast Cancer

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689623"> Plasticity of Extrachromosomal and Intrachromosomal BRAF
           Amplifications in Overcoming Targeted Therapy Dosage Challenges

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689624"> A Natural Polyphenol Exerts Antitumor Activity and Circumvents
           Anti-PD-1 Resistance through Effects on the Gut Microbiota

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689613"> Deconvolving Clinically Relevant Cellular Immune Cross-talk from
           Bulk Gene Expression Using CODEFACS and LIRICS Stratifies Patients with
           Melanoma to Anti-PD-1 Therapy

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689604"> Subversion of Serotonin Receptor Signaling in Osteoblasts by
           Kynurenine Drives Acute Myeloid Leukemia

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689617"> Cancer Induces a Stress Ileopathy Depending on β-Adrenergic
           Receptors and Promoting Dysbiosis that Contributes to Carcinogenesis

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689608"> Phase Separation Mediates NUP98 Fusion Oncoprotein Leukemic
           Transformation

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689579"> Moonshot Redux to Focus on Prevention, Screening

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689599"> Robert Califf Back as FDA Head

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689598"> Safety Concerns Prompt Pause of Magrolimab Trials

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689597"> CAR T Cells Detectable More than 10 Years Later

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689596"> Sotorasib Tackles KRASG12C-Mutated Pancreatic Cancer

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689595"> Rare Ovarian Cancer's First Positive Trial

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689594"> First Drug Approved for Rare Eye Cancer

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689593"> Noted

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689618"> Dual Immunotherapy Makes Strides against HCC

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689616"> Probing Early-Onset Colorectal Cancer

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689622"> Two Driver Mutations Exist in Osimertinib-Resistant Patient
           Tumors

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689621"> Lactic Acid Supports an Immunosuppressive Environment and Reduces
           ICB Response

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689589"> Somatic Mutations Show Immunogenicity in Metastatic Breast
           Cancer

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689615"> Anti-PD-1 Therapy Reverses HIV Latency in Patients with HIV
           and Cancer

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689601"> Neural Progenitors Promote Malformations in Tuberous Sclerosis
           Complex

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689592"> Genomic Alterations Distinguish Patterns of Metastatic
           Dissemination

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689591"> Fungal Mycobiome Drives IL33 Secretion and TH2 Infiltration in
           PDAC

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689600"> Multikinase Inhibition Induces Tumor Microenvironment
           Remodeling in PDAC

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689620"> Akk Abundance Alters Survival in Patients with NSCLC on ICIs

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689588"> Microbial Metabolism Activates Immune-Suppressive Tumor
           Macrophages

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689585"> EGFR Mutations in GBM Alter Ligand Binding and Subsequent
           Dimerization

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689590"> GD2-Targeting CAR T Cells Show Promise in H3K27M-Mutated
           Gliomas

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689603"> CDK4/6 Inhibition Shows Clinical Activity in p16ink4A-Deficient
           Mesothelioma

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689586"> TIL Transcriptomic States Enable Successful TCR Prediction

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689619"> GABA Supports Tumor Progression Through β-catenin
           Activation

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689584"> Extracellular Matrix Elasticity Promotes Metastatic Therapy
           Resistance

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689587"> A Base Editing Platform Shows Function of Cancer-Associated
           Variants

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
  • 689614"> Antibodies Against Cleaved CDCP1 Show Activity in RAS-Mutant
           Tumors

    • Free pre-print version: Loading...

      PubDate: 2022-04-09T23:20:50-05:00
      Issue No: Vol. 12, No. 4 (2022)
       
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
 


Your IP address: 44.192.92.49
 
Home (Search)
API
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-